Viveve Medical, Inc. (VIVE) Social Stream
VIVEVE MEDICAL INC (VIVE) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering VIVE.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
Price Target Last Issued November 14, 2022
The Trend in the Analyst Price Target
Over the past 30 months, VIVE's average price target has gone up $4.25.
VIVE reports an average of 828.35% for its upside potential over the past 34 weeks.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
VIVE Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
Over the past 35 weeks, VIVE's average broker recommendation rating improved by 0.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for VIVE as an investment opportunity.
- VIVEVE MEDICAL INC's upside potential (average analyst target price relative to current price) is greater than 297.94% of all US stocks.
- To contextualize these metrics, consider that out of all US stocks, VIVEVE MEDICAL INC's number of analysts covering the stock is higher than 3.49% of them.
- In terms of how VIVEVE MEDICAL INC fares relative to Healthcare stocks, note that its variance in analysts' estimates is lower than 83.31% of that group.
- VIVEVE MEDICAL INC's average analyst price target is higher than 34.31% of Medical Equipment stocks.
Make investment decisions regarding VIVE using the data that counts. Try POWR Ratings for free.